Log in
OTCMKTS:VEGPF

Vectura Group Stock Forecast, Price & News

$1.53
0.00 (0.00 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.53
Now: $1.53▼
$1.53
50-Day Range
$1.32
MA: $1.37▼
$1.53
52-Week Range
$0.80
Now: $1.53▼
$1.53
VolumeN/A
Average Volume6,800 shs
Market Capitalization$924.52 million
P/E RatioN/A
Dividend YieldN/A
Beta0.41
Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri, Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta, Anoro Ellipta, and Trelegy Ellipta for the treatment of COPD. It is also developing VR315 (US) for the treatment of asthma and COPD.In addition, the company offers dry powder inhalers, pressurized metered dose inhalers, and nebulized devices. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.46 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:VEGPF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.vectura.com
Phone44-0-12-4966-7700
Employees480

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio25.50
P/E GrowthN/A

Sales & Book Value

Annual Sales$227.68 million
Price / Sales4.06
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.89 per share
Price / Book1.72

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares604,260,000
Market Cap$924.52 million
Next Earnings DateN/A
OptionableNot Optionable
$1.53
0.00 (0.00 %)
(As of 11/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VEGPF News and Ratings via Email

Sign-up to receive the latest news and ratings for VEGPF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Vectura Group (OTCMKTS:VEGPF) Frequently Asked Questions

How has Vectura Group's stock price been impacted by Coronavirus (COVID-19)?

Vectura Group's stock was trading at $1.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, VEGPF stock has increased by 36.6% and is now trading at $1.53.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Vectura Group?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vectura Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Vectura Group.

What stocks does MarketBeat like better than Vectura Group?

Wall Street analysts have given Vectura Group a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Vectura Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Vectura Group?

Vectura Group saw a decline in short interest in the month of October. As of October 30th, there was short interest totaling 400 shares, a decline of 33.3% from the October 15th total of 600 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 4.0 days.
View Vectura Group's Short Interest.

Who are some of Vectura Group's key competitors?

Some companies that are related to Vectura Group include FibroGen (FGEN), Apellis Pharmaceuticals (APLS), MorphoSys (MOR), Deciphera Pharmaceuticals (DCPH), Eidos Therapeutics (EIDX), Agios Pharmaceuticals (AGIO), Nektar Therapeutics (NKTR), Alkermes (ALKS), Harmony Biosciences (HRMY), ALX Oncology (ALXO), Pacira BioSciences (PCRX), Atea Pharmaceuticals (AVIR), Global Blood Therapeutics (GBT), Axsome Therapeutics (AXSM) and Seres Therapeutics (MCRB).
View all competitors.

Who are Vectura Group's key executives?

Vectura Group's management team includes the following people:
  • Mr. William Downie, CEO & Exec. Director (Age 53)
  • Mr. Paul Andrew Fry, CFO & Exec. Director (Age 53)
  • Mr. Anthony Fitzpatrick, Exec. VP of Operations
  • Dr. Geraldine Venthoye, Chief Scientific Officer & Exec. VP of Product Devel.
  • Elizabeth Knowles, VP of Investor Relations
  • Mr. John Murphy, Gen. Counsel & Company Sec. (Age 67)
  • David Ginivan, VP of Corp. Communications
  • Ms. Christina Olsen, Exec. VP of Corp. Strategy & Communications
  • Ms. Joanne Hombal, Exec. VP of HR (Age 46)
  • Mr. Roger Heerman, Exec. VP of Commercial & Bus. Devel. (Age 47)

What is Vectura Group's stock symbol?

Vectura Group trades on the OTCMKTS under the ticker symbol "VEGPF."

How do I buy shares of Vectura Group?

Shares of VEGPF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vectura Group's stock price today?

One share of VEGPF stock can currently be purchased for approximately $1.53.

How big of a company is Vectura Group?

Vectura Group has a market capitalization of $924.52 million and generates $227.68 million in revenue each year. The company earns $-28,220,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. Vectura Group employs 480 workers across the globe.

What is Vectura Group's official website?

The official website for Vectura Group is www.vectura.com.

How can I contact Vectura Group?

Vectura Group's mailing address is One Prospect West, Wiltshire X0, SN14 6FH. The company can be reached via phone at 44-0-12-4966-7700 or via email at [email protected]

This page was last updated on 11/27/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.